Clinical trials: Psychotherapy
Diagnosis of Schizophrenia Spectrum Disorders
Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)
People with schizophrenia spectrum disorders are faced with significant metacognitive impairments that include difficulties in their ability to form complex representations of the self and others.
- Trial name
- NCT03427580
- Testing
- MERIT
- Where
- Israel
- Volunteers
- 54 people
- Sponsor
- Bar-Ilan University, Israel
Fibromyalgia
Drug and Talk Therapy for Fibromyalgia
Fibromyalgia Syndrome (FMS) afflicts 2% of the U.S. population and have huge individual and societal costs in terms of quality of life, social and work functioning, health care use, and lost productivity.
- Trial name
- NCT01038323
- Testing
- CBT and milnacipran, Educational with milnacipran
- Where
- United States
- Volunteers
- 58 people
- Sponsor
- Indiana University
Posttraumatic Stress Disorder (PTSD)
Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD
The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective in people with chronic, treatment-resistant PTSD.
- Trial name
- NCT01689740
- Testing
- Full Dose MDMA-assisted therapy (125 mg), Open-Label Full Dose MDMA-assisted therapy (125 mg), Psychotherapy
- Where
- Israel
- Volunteers
- 10 people
- Sponsor
- Resilient Pharmaceuticals
Diabetes Mellitus, Depression
Behavioral Activation Therapy for Rural Veterans With Diabetes and Depression
This clinical trial will compare the effectiveness of the Healthy Outcomes through Patient Empowerment (HOPE) intervention to enhanced usual care (EUC) for diabetes and depression at 6 and 12 month follow-up.
- Trial name
- NCT01572389
- Testing
- Healthy Outcomes through Patient Empowerment (HOPE), Enhanced Usual Care
- Where
- United States
- Volunteers
- 225 people
- Sponsor
- VA Office of Research and Development